Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-31

FDA Approved: GLIMEPIRIDE — Supplemental Application (Carlsbad Technology, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glimepiride from Carlsbad Technology, Inc., granting approval to market a generic form of the diabetes medication. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)